Feb 3 (Reuters) - AstraZeneca said on Tuesday the U.S. health regulator has rejected its application for a self-injectable ...
The company is working with the U.S. regulator to move forward with an updated application, adding a decision is expected in ...
By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...
THE Food and Drug Administration (FDA) warned the public against the presence of a counterfeit version of an anti-rabies ...
The FDA laid out the qualifications a site would need to qualify for PreCheck on a webpage where companies can also submit ...
The U.S. Food and Drug Administration (FDA) has approved a drug to control seizures in dogs with idiopathic epilepsy, a type ...
Corcept’s relacorilant was rejected for hypercortisolism late last year—a decision which CEO Joseph Belanoff expressed surprise with at the time.
By Kamal Choudhury Jan 30 (Reuters) - Shares of Corcept Therapeutics fell 16% on Friday after a corrected "complete response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results